Discovery of 4H-chromeno[2,3-d]pyrimidin-4-one derivatives as senescence inducers and their senescence-associated antiproliferative activities on cancer cells using advanced phenotypic assay-Reference-Cited by-同舟云学术

Discovery of 4H-chromeno[2,3-d]pyrimidin-4-one derivatives as senescence inducers and their senescence-associated antiproliferative activities on cancer cells using advanced phenotypic assay

Published:2021-01 Issue: Volume:209 Page:112550
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Oh Sangmi,Lee Ji Young,Choi Inhee,Ogier Arnaud,Kwon Do Yoon,Jeong Hangyeol,Son Sook Jin,Kim Youngmi,Kwon Haejin,Park Seijin,Kang Hwankyu,Kong Kwanghan,Ahn Sujin,Nehrbass Ulf,Kim Myung Jin,Song Rita

Funder

National Research Foundation of Korea

Ministry of Science and ICT, South Korea

Ministry of Science, ICT and Future Planning

Korea Institute of Science and Technology Information

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference47 articles.

1. Cancer Facts and Figures 2019;American Cancer Society,2019

2. Cancer statistics;Siegel;CA A Cancer J. Clin.,2019

3. Dual fronts poised to transform melanoma therapy;Mullard;Nat. Rev. Drug Discov.,2011

4. Vemurafenib: the first drug approved for BRAF-mutant cancer;Bollag;Nat. Rev. Drug Discov.,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent methods in the synthesis of chromeno[2,3-d]pyrimidines;Chemistry of Heterocyclic Compounds;2024-04

2. Regioselective synthesis of substituted tetrahydrochromeno[2,3-d]pyrimidin-2-ones and -pyrimidine-2-thiones;Russian Chemical Bulletin;2023-06

3. Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies;Biochemical Pharmacology;2022-05

4. Identification of Piperidine-3-carboxamide Derivatives Inducing Senescence-like Phenotype with Antimelanoma Activities;ACS Medicinal Chemistry Letters;2021-03-22